Sports fans will have the chance to question legends such as Andy Nicol and Mark Hateley
Sporting legends are set to take part in special question and answer sessions to raise funds for a cancer charity.
Top sports personalities are continuing to sign up to support Beatson Cancer Charity’s latest fundraising efforts with virtual fan exclusive Q&A sessions.
Beatson Banter gives sporting fans the priceless opportunity to pose questions to sporting legends and bid for some exclusive memorabilia.
Scottish rugby star Andy Nicol kicks off the three online events on Thursday 25 February, before passing the baton to ‘The Jarrow Arrow’ Steve Cram CBE on Thursday 11 March and then it’s a double header with Old Firm hitmen Mark Hateley and John Hartson on Thursday 25 March.
Each Beatson Banter session is one hour, tickets are £10 each or book your tickets before 25 February and enjoy all three sessions for the reduced price of £25.
Now, more than ever, Beatson Cancer charity needs your help. Fundraising efforts are strained, and public support is crucial in order to help keep the charity’s services running.
Martin Cawley, Beatson Cancer Charity chief executive, said: "As a result of the Covid-19 crisis, Beatson Cancer Charity has had to make significant changes to the way we operate. We are delighted to continue to deliver some fun events digitally.
“We can still have a positive impact on patients' lives and support our NHS colleagues at the Beatson. We continue to fund radiographers and clinical nurse specialists who are working harder than ever to provide enhanced care and support to vulnerable cancer patients. We are doing all we can to continue to help our colleagues at The Beatson West of Scotland Cancer Centre and continue to fund life-saving research.”
Mark Hateley said: “I'm thrilled to be supporting Beatson Banter and look forward to questions from the audience and being put through my paces!”
Beatson Cancer Charity supports people affected by cancer, every step of the way. They provide services, as well as funding specialists, research and education to invest in a better future for cancer patients and their families.